Characterized traits in studied UPEC isolates – prevalence and distribution among phylogenetic groups.
1. Introduction
UTIs are one of the most frequently acquired bacterial infections and
Of serious concern and an increasing health problem, on a global scale, is the appearance and spread of antimicrobial resistance. One of the major health care concerns is emergence of multidrug resistant bacteria and clinical microbiologists increasingly agree that multidrug resistant Gram-negative bacteria pose the greatest risk to public health (Kumarasamy et al., 2010). Therefore, it is essential to determine susceptibility of pathogenic strains for antimicrobial agents and association of antimicrobial resistance with virulence genes.
One of the means for acquiring specific virulence factor genes and antimicrobial resistance genes, is via mobile DNA (
The search for alternative antibacterial agents is of great importance and colicins, toxic, narrow killing spectrum exhibiting proteins produced by colicinogenic
In summary, to diminish the burden of UPEC, using effective preventive measures, data on phylogenetic groups, serogroups, virulence factor prevalence, antimicrobial resistance, presence of mobile DNA, colicin production and colicin resistance among
In Slovenia in 2002, we collected 110
2. Phylogenetic groups and subgroups
Analysis of our collection of 110 UPEC isolates showed that 55 (50%) belonged to group B2, 28 (25%) to A, 21 (19%) to D, and 6 (5%) to the B1 group (Rijavec et al., 2006). When subgroups were considered the distribution of the isolates was: 4 (4%) of the studied isolates belonged to the subgroup A0, 24 (22%) to A1, 6 (5%) to B22, 49 (45%) to B23, 16 (15%) to D1 and 5 (5%) to D2 (our unpublished data).
The obtained distribution of the studied isolates into the phylogenetic groups, with the large majority classifying to the B2 group was expected since, it is known that ExPEC isolates mainly belong to the B2 phylogenetic group (Picard et al., 1999) however, the disproportionate distribution into the B22 (5%) and B23 (45%), and A0 (4%) and A1 (22%) subgroups was surprising.
3. Serogroups
Serotyping of
Serotyping of the 110 uropathogenic strains revealed that 77 (70%) were O-antigen typable, 19 (17%) were O-nontypable, and 14 (12.7%) were rough. Sixty-three (57%) of the examined strains were H-antigen typable, 41 (37%) were H-antigen negative, and 6 (5%) were H-antigen nontypable. The O-typable strains were distributed into 31 serogroups. Nevertheless, the most frequent were O2 (9 isolates) and serotype O6:H1 (10 isolates). Five common serotypes were identified in three or more strains: O2:HNT (n = 3), O2:H6 (n = 3),
O6:H1 (n = 10), O7:HNT (n = 3), and O74:H39 (n = 4) accounting for 30% of the serotypable isolates. A number of other serotypes were detected in one or two strains (Rijavec et al., 2006).
Serotype analysis of the studied strains revealed that they belonged to diverse serogroups. However, the most frequent were O2 and O6, which are well established as associated with urinary tract infections. The large majority, 96%, of the O2 and O6 isolates were assigned to the B2 phylogenetic group (Rijavec et al., 2006).
4. Virulence factors
Any component of a microbe that is required for, or potentiates its ability to cause disease is designated as a virulence factor. Many different virulence factors exist however, they can all be placed in one of the four major groups of virulence factors: adhesins, toxins, iron uptake systems and host immunity evading systems. Hence, virulence factors facilitate colonization and invasion of the host, avoidance or disruption of host defence mechanisms, injury to host tissue, and/or stimulation of a noxious host inflammatory response (Johnson and Steel, 2000).
4.1. Adhesins
Among the first virulence factors that come into play during establishment of an infection are adhesins. Besides their primary role as adhesin molecules, they can also function as invasins, promoters of biofilm formation and transmitors of signals to epithelial cells resulting in inflammation. Various adhesins have been identified and studied (Zhang & Foxman, 2003). In our analysis we focused on the four mostly studied: type 1 fimbriae, P fimbriae, S fimbriae and the Afa/Dr family of adhesins (Starčič Erjavec & Žgur-Bertok, 2008).
Type 1 fimbriae are the most common adhesive organelles of
P fimbriae are among the best studied fimbrial adhesive fibres of UPEC strains. The P fimbrial adhesin molecule (PapG) recognizes globoseries of glycolipids as receptors (Zhang & Foxman, 2003). In our study the
S fimbriae bind to sialyl galactosides. Studies showed that
The Afa/Dr family consists of 13 known adhesins that all bind to the Dra blood group antigen present on the complement regulatory molecule CD55, also known as decay-accelerating factor (DAF) (Bower et al., 2005). The
Among the tested adhesin genes in the studied UPEC isolates (Table 1), the type 1 fimbriae were the most prevalent - the
Analysis of the distribution of adhesin gene sequences among phylogenetic groups revealed that adhesin gene sequences were differently distributed (Table 1):
Further, a very high, statistically significant, prevalence of S fimbriae in the B2 group was detected, 45% of the strains belonging to the B2 group harboured
4.2. Toxins
Toxins affect an astonishing variety of fundamental eukaryotic processes and thereby harm the host (Kaper, 2004) and are important virulence factors in a variety of
In pathogenic
Well known toxins are also invasins, the Ibe proteins that help
Among the screened toxin encoding genes in the studied UPEC isolates (Table 1), the
Analysis of the distribution of toxin encoding genes among the determined phylogenetic groups of studied strains (Table 1) revealed that the tested toxin encoding genes
Total (N=110) | A (N=28) | B1 (N=6) | B2 (N=55) | D (N=21) | |
107 (97) | 28 (26) | 5 (5) | 53 (50) | 21 (20) | |
54 (49) | 8 (15) | 1 (2) | 35 (65) | 10 (19) | |
37 (34) | 5 (14) | 1 (3) | 21 (57) | 10 (27) | |
14 (13) | 0 (0) | 0 (0) | 14 (100) | 0 (0) | |
26 (24) | 1 (4) | 0 (0) | 25 (96) | 0 (0) | |
2 (2) | 1 (50) | 0 (0) | 1 (50) | 0 (0) | |
28 (25) | 1 (4) | 0 (0) | 26 (93) | 1 (4) | |
25 (23) | 0 (0) | 0 (0) | 25 (100) | 0 (0) | |
10 (9) | 0 (0) | 0 (0) | 9 (90) | 1 (10) | |
48 (44) | 1 (2) | 0 (0) | 42 (88) | 5 (10) | |
46 (42) | 8 (17) | 0 (0) | 27 (59) | 11 (24) | |
51 (46) | 9 (18) | 0 (0) | 41 (80) | 1 (2) | |
22 (20) | 4 (18) | 0 (0) | 12 (55) | 6 (27) | |
84 (76) | 17 (20) | 3 (4) | 49 (58) | 15 (18) | |
K1 | 6 (5) | 1 (17) | 1 (17) | 4 (67) | 0 (0) |
K5 | 11 (10) | 2 (18) | 1 (9) | 8 (73) | 0 (0) |
63 (57) | 20 (32) | 4 (6) | 29 (46) | 10 (16) | |
23 (21) | 0 (0) | 0 (0) | 23 (100) | 0 (0) | |
Ampicillin | 57 (52) | 12 (21) | 5 (9) | 32 (56) | 18 (32) |
Ciprofloxacin | 99 (90) | 23 (23) | 5 (5) | 52 (53) | 19 (19) |
Chloramphenicol | 50 (45) | 7 (14) | 3 (6) | 32 (64) | 8 (16) |
Kanamycin | 95 (86) | 20 (21) | 5 (5) | 51 (54) | 19 (20) |
Mezlocillin | 59 (54) | 12 (20) | 5 (8) | 34 (58) | 8 (14) |
Nalidixic acid | 64 (58) | 12 (19) | 3 (5) | 38 (59) | 11 (17) |
Norfloxacin | 99 (90) | 23 (23) | 5 (5) | 52 (52) | 19 (19) |
Streptomycin | 69 (63) | 15 (22) | 5 (7) | 40 (60) | 9 (13) |
Sulfamethoxazole-Trimethoprim | 87 (79) | 18 (21) | 6 (7) | 49 (56) | 14 (16) |
Tetracycline | 47 (43) | 6 (13) | 4 (9) | 33 (70) | 4 (9) |
Trimethoprim | 72 (65) | 14 (19) | 6 (8) | 41 (57) | 11 (15) |
RepFIA | 20 (18) | 7 (35) | 0 (0) | 10 (50) | 3 (15) |
RepFIB | 57 (52) | 18 (32) | 2 (4) | 26 (46) | 11 (19) |
RepFIIA | 24 (22) | 7 (29) | 0 (0) | 15 (63) | 2 (8) |
Integron | 34 (31) | 12 (35) | 1 (3) | 12 (35) | 9 (26) |
42 (38) | 12 (29) | 3 (7) | 20 (48) | 7 (17) |
4.3. Iron uptake systems
Iron is an essential cofactor for many basic metabolic pathways and bacteria have developed specialized iron uptake systems to capture iron. The most prominent are the siderophores, iron-binding molecules that are taken up by special siderophore receptors and ATP-consuming porin-like transporters in the bacterial outer membrane (Schaible & Kaufmann, 2004). Siderophores can be classified into three groups: (i) the catecholate type (enterobactin, salmochelin = enterochelin), (ii) hydroxamate type (aerobactin) and (iii) a mixed type - a combination of both (yersiniabactin) (Grass, 2006; Schaible & Kaufmann, 2004). In addition to siderophore synthesis strains can use siderophores produced and released into the extracellular medium by other bacteria and even fungi. In the host, bacteria may use iron sources such as heme, hemoglobin, hemopexin, and iron bound to transferrin and lactoferrin (Braun & Braun, 2002). Apart from the siderophores and their receptors, autotransporters, virulence-associated proteins in gram-negative bacteria, can also play a role in obtaining iron for example, the hemoglobin protease Hbp (Otto et al., 2002). All autotransporter proteins are energy-independent secreted via a type 5 secretion system and possess an overall unifying structure, comprising (i) an amino-terminal leader peptide (for secretion across the inner membrane), (ii) the secreted mature protein (or passenger domain), and (iii) a dedicated C-terminal domain, which forms a pore in the outer membrane through which the passenger domain passes to the cell surface (Henderson & Nataro, 2001).
In our study the following iron uptake systems genes were investigated (Table 1):
Analysis of the distribution of iron uptake systems encoding genes among the determined phylogenetic groups of studied strains (Table 1) revealed that all of the studied iron uptake systems were mostly harboured by UPEC strains belonging to the B2 phylogenetic group, as 41 (80%) of the strains harbouring
4.4. Host immunity evading systems
Pathogenic microbes avoid host defences using a wide array of virulence factors, ranging from polysaccharide capsules, serum resistance proteins to immune system modulating agents (Kaper et al., 2004).
Capsules are the discrete structural layers of extracellular polysaccharides that envelope the cell and allow the bacteria to evade or counteract the host immune system (Roberts, 1996). Capsules protect pathogens from assaults such as opsonophagocytosis and complement-mediated killing (Roberts, 1995); and in case of acidic capsules they can act as “sponges” to sequester and neutralize antimicrobial peptides (Llobet et al., 2008). Virtually all UPEC have a K-type polysaccharide capsule. Most UPEC express Group 2 or 3 capsules on their surfaces (Goller and Seed, 2010) and the K-antigens K1, K5, K30 and K92 are the most prevalent among UPEC (Johnson, 1991).
TraT, the surface exclusion protein of the plasmid transfer system, has been implicated in increased serum resistance (Binns et al., 1979). TraT is one of the most prevalent virulence factors in pathogenic
Recently, TcpC, a Toll/interleukin-1 receptor (TIR) domain–containing protein of uropathogenic
Among the 110 studied UPEC isolates (Table 1) 6 (5%) had the K1-capsule and 11 (10%) had the K5-capsule (Starčič Erjavec et al., 2007). The
Analysis of the distribution of the studied immune system evading characteristics among the determined phylogenetic groups (Table 1) showed that, isolates with K1- and K5-capsules were the most prevalent in the B2 group, 4 (67%) and 8 (73%), respectively however, capsule possessing isolates also belonged to the A and B1 group, albeit at low prevalence. One (17%) K1-capsule coated strain was found in the A and one in the B1 group and 2 (18%) K5-capsule coated strains in the A group and one (9%) in the B1 group. The
5. Antimicrobial susceptibility
An important task in clinical microbiology is the performance of antimicrobial susceptibility testing in order to detect possible drug resistance in common pathogens and to assure susceptibility to drugs of choice for particular infections (Jorgensen & Ferraro, 2009). Therefore, several studies on the subject of antimicrobial susceptibility and
In the year 2002, when the studied isolates were collected, treatment of UTI in outpatients in Slovenia was as follows: a course of antibiotics (therapy of choice - trimethoprim 160 mg or trimethoprim/sulfamethoxazole 160 mg/800 mg twice daily for 3 days) and advice to consume sufficient quantities of liquids (2–3 l per day) (Car et al., 2003).
The studied uropathogenic strains were screened for susceptibility to the following antibiotics: ampicillin, chloramphenicol, kanamycin, streptomycin, tetracycline, trimethoprim, trimethoprim-sulfamethoxazole, ciprofloxacin, norfloxacin, nalidixic acid, mezlocillin, amikacin, cefotaxime, cefotiame, cefoxitin, ceftazidime, and gentamicin. Susceptibilities to the tested antibiotics ranged from 109 (99%) susceptible to amikacin, cefotaxime, ceftazidime, to 47 (43%) susceptible to tetracycline. Antibiotics with the highest prevalence of susceptibility, apart from amikacin, cefotaxime, ceftazidime, were to cefotiame, cefoxitin, and gentamicin as 108 (98%), 103 (94%), and 101 (92%) of the studied strains, respectively, were susceptible. Antibiotics with the lowest prevalence of susceptibility, apart from tetracycline, were to chloramphenicol, ampicilin, mezlocillin and nalidixic acid, as 50 (45%), 57 (52%), 59 (54%) and 64 (58%), respectively, were susceptible (Rijavec et al., 2006).
Forty-six (42%) of the studied strains were resistant to more than three classes of the tested antimicrobial agents—beta lactams, quinolone/fluoroquinolone, trimethoprim/ trimethoprim-sulfamethoxazole, tetracycline, chloramphenicol, aminoglycosides (streptomycin, kanamycin)—and were designated as multidrug resistant (MDR). Subsequently, the association between MDR and the phylogenetic group was examined. A statistically significant correlation between non-MDR and the B2 group was determined and a significant correlation between MDR and the D phylogenetic group was found. On the other hand, there were no statistically significant correlations between MDR or non-MDR strains and the A or B1 groups (Rijavec et al., 2006).
6. Mobile genetic elements
The loss and gain of mobile genetic elements has a pivotal role in shaping the genomes of pathogenic bacteria. Horizontal gene transfer is an important mechanism that rapidly disseminates new traits to recipient organisms. Acquiring these new traits is crucial in promoting the fitness and survival of a pathogen while it coevolves with its host (Croxen & Finlay, 2010).
Bacterial plasmids, self-replicating, extrachromosomal elements are key agents of change in microbial populations. They promote the dissemination of a variety of traits, including virulence, enhanced fitness, resistance to antimicrobial agents, and metabolism of rare substances (Johnson & Nolan, 2009).
Integrons are assembly platforms that incorporate exogenous open reading frames by site-specific recombination and convert them to functional genes by ensuring their correct expression. Integrons are composed of three key elements necessary for the capture of exogenous genes: a gene (
The studied UTI strains were screened for replication regions of IncFI and IncFII plasmids. We found (Table 1) a high (62 strains, 56%) incidence of
Since only class 1, 2 and 3 of integrons were shown to be associated with pathogenic
7. Colicins
Colicins are bacteriocins produced by
Among the studied UPEC isolates 42 (38%) exhibited colicinogenic activity (Starčič Erjavec et al., 2006). Each of the 110 UPEC strains was resistant to at least 3 colicinogenic strains from Pugsley's collection of colicinogenic strains (Pugsley & Oudega, 1987), 23 UPEC strains (21%) were resistant to all 20 tested Pugsley's strains (our unpublished data). Colicinogenic strains were found in all four phylogenetic groups (Table 1) however, most colicinogenic strains, 20 (48%) belonged to the B2 group (our unpublished data).
8. Conclusion
Our investigation of UPEC isolates from Slovenia revealed a high prevalence of drug resistance and multidrug resistance. The virulence profile of the examined strains was comparable to that of strains from other geographic regions.
Acknowledgments
This work was supported by the by grant P1-0198 from the Slovenian Research Agency.
References
- 1.
Alekshun M. N. Levy S. B. 2007 Molecular mechanisms of antibacterial multidrug resistance. ,128 6 March 2007),1037 1050 0092-8674 - 2.
Ananias M. Yano T. 2008 Serogroups and virulence genotypes of isolated from patients with sepsis. Brazilian Journal of Medical and Biological Research,41 10 October 2008),877 883 0010-0879 X - 3.
Bauer R. J. Zhang L. Foxman B. Siitonen A. Jantunen M. E. Saxen H. Marrs C. F. 2002 Molecular epidemiology of 3 putative virulence genes for urinary tract infection- usp, iha and iroN(E. coli). The Journal of Infectious Diseases,185 10 May 2002),1521 1524 0022-1899 - 4.
Binns M. M. Davies D. L. Hardy K. G. 1979 Cloned fragments of the plasmid ColV,I-K94 specifying virulence and serum resistance. ,279 5716 June 1979),778 781 0028-0836 - 5.
Boerlin P. Reid-Smith R. J. 2008 Antimicrobial resistance: its emergence and transmision. ,9 2 December 2008),115 126 1466-2523 - 6.
Bower J. M. Eto D. S. Mulvey M. A. 2005 Covert operations of uropathogenic within the urinary tract. Traffic6 1 January 2005),18 31 1398-9219 - 7.
Braun V. Braun M. 2002 Iron transport and signaling in . FEBS Letters,529 1 October 2002),78 85 0014-5793 - 8.
Car J. Švab I. Kersnik J. Vegnuti M. 2003 Management of lower urinary tract infection in women by Slovene GPs. ,20 4 August 2003),452 456 0263-2136 - 9.
Cirl C. Wieser A. Yadav M. Duerr S. Schubert S. Fischer H. Stappert D. Wantia N. Rodriguez N. Wagner H. Svanborg C. Miethke T. 2008 Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins.14 4 April 2008),399 406 1078-8956 - 10.
Clermont O. Bonacorsi S. Bingen E. 2000 Rapid and simple determination of the phylogenetic group. Applied and Environmental Microbiology,66 10 October 2010),4555 4558 0099-2240 - 11.
Croxen M. A. Finlay B. B. 2010 Molecular mechanisms of pathogenicity. Nature Reviews Microbiology,8 1 January 2010),26 38 1740-1526 - 12.
Couturier M. Bex F. Bergquist P. L. Maas W. K. 1988 Identification and classification of bacterial plasmids. ,52 3 September 1988),375 395 0146-0749 - 13.
Daw M. A. Falkiner F. R. 1996 Bacteriocins: nature, function and structure. ,27 6 December 1996),467 479 0968-4328 - 14.
Dobrindt U. Chowdary M. G. Krumbholz G. Hacker J. 2010 Genome dynamics and its impact on evolution of . Medical Microbiology and Immunology,199 3 August 2010),145 154 0300-8584 - 15.
Escobar-Paramo P. Grenet K. Le Menac’h A. Rode L. Salgado E. Amorin C. Gouriou S. Picard B. Rahimy M. C. Andremont A. Denamur E. Ruimy R. 2004 Large-scale population structure of human commensal isolates. Applied and Environmental Microbiology,70 9 September 2004),5698 5700 0099-2240 - 16.
Feldgarden M. Riley M. A. 1998 High levels of colicin resistance in . Evolution,52 5 October 1998),1270 1276 0014-3820 - 17.
Goller C. C. Seed P. C. 2010 Revisiting the polysaccharide capsule as a virulence factor during urinary tract infection: contribution to intracellular biofilm development. Virulence,1 4 July-August 2010),337 337 2150-5594 - 18.
Grass G. 2006 Iron transport in : all has not been said and done. Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine,19 2 April 2006),159 172 0966-0844 - 19.
Henderson I. R. Nataro J. P. 2001 Virulence functions of autotransporter proteins.69 3 March 2001),1231 1243 0019-9567 - 20.
Johnson J. R. 1991 Virulence factors in urinary tract infection. Clinical Microbiology Reviews4 1 January 1991),80 128 0893-8512 - 21.
Johnson J. R. Stell A. L. 2000 Extended virulence genotypes of strains from patients with urosepsis in relation to phylogeny and host compromise. The Journal of Infectious Diseases,181 1 January 2000),261 272 0022-1899 - 22.
Johnson J. R. Kuskowski M. A. Gajewski A. Soto S. Horcajada J. P. Jimenez de Anta. M. T. Vila J. 2005a Extended virulence genotypes and phylogenetic background of isolates from patients with cystitis, pyelonephritis, or prostatitis. The Journal of Infectious Diseases,191 1 January 2005),46 50 0022-1899 - 23.
Johnson J. R. Owens K. Gajewski A. Kuskowski M. A. 2005 Bacterial characteristics in relation to clinical source of isolates from women with acute cystitis or pyelonephritis and uninfected women. Journal of Clinical Microbiology,43 12 December 2005),6064 6072 0095-1137 - 24.
Johnson T. J. Nolan L. K. 2009 Pathogenomics of the virulence plasmids of . Microbiology and Molecular Biology Reviews : MMBR,73 4 December 2009),750 774 1092-2172 - 25.
Jorgensen J. H. Ferraro M. J. 2009 Antimicrobial susceptibility testing: a review of general principles and contemporary practices.49 11 December 2009),1749 1755 1058-4838 - 26.
Kado C. I. 1998 Origin and evolution of plasmids. ,73 1 January 1998),117 126 0003-6072 - 27.
Kahlmeter G. Menday P. 2003 Cross-resistance and associated resistance in 2478 isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. The Journal of Antimicrobial Chemotherapy,52 1 July 2003),128 131 0305-7453 - 28.
Kaper J. B. Nataro J. P. Mobley H. L. T. 2004 Pathogenic . Nature Reviews Microbiology,2 2 February, 2004),123 140 1740-1526 - 29.
Karlowsky J. A. Thornsberry C. Jones M. E. Sahm D. F. 2003 Susceptibility of antimicrobial-resistant urinary isolates to fluoroquinolones and nitrofurantoin. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America,36 2 January 2003),183 187 1058-4838 - 30.
Kumarasamy K. K. Toleman M. A. Walsh T. R. Bagaria J. Butt F. Balakrishnan R. Chaudhary U. Doumith M. Giske C. G. Irfan S. Krishnan P. Kumar A. V. Maharjan S. Mushtaq S. Noorie T. Paterson D. L. Pearson A. Perry C. Pike R. Rao B. Ray U. Sarma J. B. Sharma M. Sheridan E. Thirunarayan M. A. Turton J. Upadhyay S. Warner M. Welfare W. Livermore D. M. Woodford N. 2010 Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. ,10 9 September 2010),597 602 1473-3099 - 31.
Kurazono H. Yamamoto S. Nakano M. Nair G. B. Terai A. Chaicumpa W. Hayashi H. 2000 Characterization of a putative virulence island in the chromosome of uropathogenic possessing a gene encoding a uropathogenic-specific protein. Microbial Pathogenesis,28 3 March 2000),183 189 0882-4010 - 32.
Lindič J. 2005 Pristop k bolniku z okužbo sečil.[Accession to a patient with urinary tract infection]. In: , Z Fras & P. Poredoš, (Eds.),137 148 University of Ljubljana, Medical Faculty,9-61626-470-2 Slovenia - 33.
Llobet E. Tomás J. M. Bengoechea J. A. 2008 Capsule polysaccharide is a bacterial decoy for antimicrobial peptides.154 No.Pt 12, (December 2008),3877 3886 1350-0872 - 34.
Marrs C. F. Zhang L. Foxman B. 2005 mediated urinary tract infections: Are there distinct uropathogenic E. coli (UPEC) pathotypes? FEMS Microbiology Letters,252 2 November 2005),183 190 0378-1097 - 35.
Martinez J. J. Mulvey M. A. Schilling J. D. Pinkner J. S. Hultgren S. J. 2000 Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. ,19 12 June 2000),2803 2812 0261-4189 - 36.
Mazel D. 2006 Integrons: agents of bacterial evolution. ,4 8 August 2006),608 620 1740-1526 - 37.
Moreno E. Prats G. Sabate M. Perez T. Johnson J. R. Andreu A. 2006 Quinolone, fluroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropahtogenic . The Journal of Antimicrobial Chemotherapy,57 2 February 2006),204 211 0305-7453 - 38.
Ochman H. Whittam T. S. Caugant D. A. Selander R. K. 1983 Enzyme polymorphism and genetic population structure in and Shigella. Journal of General Microbiology,129 9 September 1983),2715 2726 0022-1287 - 39.
Oelschlaeger T. A. Dobrindt U. Hacker J. 2002 Virulence factors of uropathogens. ,12 1 January 2002),33 38 0963-0643 - 40.
Orskov F. Orskov I. 1992 serotyping and disease in man and animals. Canadian Journal of Microbiology,38 7 July 1992),699 704 0008-4166 - 41.
Otto B. R. van Dooren S. J. Dozois C. M. Luirink J. Oudega B. 2002 hemoglobin protease autotransporter contributes to synergistic abscess formation and heme-dependent growth of Bacteroides fragilis. Infection and Immunity,70 1 January 2002),5 10 0019-9567 - 42.
Picard B. Garcia J. S. Gouriou S. Duriez P. Brahimi N. Bingen E. Elion J. Denamur E. 1999 The link between phylogeny and virulence in extraintestinal infection. Infection and Immunity,67 2 February 1999),546 553 0019-9567 - 43.
Pugsley A. P. Oudega B. 1987 Methods for studying colicins and their plasmids, In: K. G. Hardy (Ed.),105 161 IRL Press Limited,0-94794-681-0 England - 44.
Rijavec M. Starčič Erjavec. M. Ambrožič Avguštin. J. Reissbrodt R. Fruth A. Križan-Hergouth V. Žgur-Bertok D. 2006 High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic (UPEC) of the four major phylogenetic groups. Current Microbiology,53 2 August 2006),158 162 0343-8651 - 45.
Rijavec M. Budič M. Mrak P. Müller-Premru M. Podlesek Z. Žgur-Bertok D. 2007 Prevalence of ColE1-like plasmids and colicin K production among uropathogenic strains and quantification of inhibitory activity of colicin K. Applied and Environmental Microbiology,73 3 February 2007),1029 1032 0099-2240 - 46.
Riley M. A. 1998 Molecular mechanisms of bacteriocin evolution. .32 255 278 0066-4197 - 47.
Riley M. A. Gordon D. M. 1996 The ecology and evolution of bacteriocins. ,17 3-4 September 1996),151 158 0169-4146 - 48.
Riley M. A. Gordon D. M. 1999 The ecological role of bacteriocins in the bacterial competition. ,7 3 March, 199),129 133 0096-6842 X - 49.
Roberts I. S. 1995 Bacterial polysaccharides in sickness and in health. The 1995 Fleming Lecture.141 No.Pt 9, (September 1995),2023 2031 1350-0872 - 50.
Roberts I. S. 1996 The biochemistry and genetics of capsular polysaccharide production in bacteria.50 285 315 0066-4227 - 51.
Russo T. A. Johnson J. R. 2000 Proposal for a new inclusive designation for extraintestinal pathogenic isolates of : ExPEC. The Journal of Infectious Diseases,181 5 May 2000),1753 1754 0022-1899 - 52.
Russo T. A. Johnson J. R. 2006 Extraintestinal isolates of : identification and prospects for vaccine development. Expert Review of Vaccines,5 1 Februar 2006),45 54 1476-0584 - 53.
Schaible U. E. Kaufmann S. H. 2004 Iron and microbial infection.2 12 December 2004),946 953 1740-1526 - 54.
Schamberger G. P. Phillips R. L. Jacobs J. L. Diez-Gonzalez F. 2004 Reduction of O157:H7 populations in cattle by addition of colicin E7-producing E. coli to feed. Applied and Environmental Microbiology,70 10 October 2004),6053 6060 0099-2240 - 55.
Servin A. L. 2005 Pathogenisis of Afa/Dr diffusely adhering . Clinical Microbiology Reviews,18 2 April 2005),264 292 0893-8512 - 56.
Stahl C. H. Callaway T. R. Lincoln L. M. Lonergan S. M. Genovese K. J. 2004 Inhibitory activities of colicins against strains responsible for postweaning diarrhea and edema disease in swine. Antimicrobial Agents and Chemotherapy,48 8 August 2004),3119 3121 0066-4804 - 57.
Starčič Erjavec. M. Rijavec M. Žgur-Bertok D. 2006 Colicins of the uropathogenic strain collection. Acta biologica slovenica,49 2 13 21 1408-3671 - 58.
Starčič Erjavec. M. Rijavec M. Križan-Hergouth V. Fruth A. Žgur-Bertok D. 2007 Chloramphenicol- and tetracycline-resistant uropathogenic (UPEC) exhibit reduced virulence potential. International Journal of Antimicrobial Agents,30 5 November 2007),436 442 0924-8579 - 59.
Starčič Erjavec. M. Žgur-Bertok D. 2008 Prevalence, distribution and genetic association of adhesin gene sequences of isolates from urinary tract infections in Slovenia. Acta biologica slovenica,51 1 21 31 1408-3671 - 60.
Starčič Erjavec. M. Križan-Hergouth V. Gubina B. Žgur-Bertok D. 2008 Prevalence of toxin encoding genes in isolates from urinary tract infections in Slovenia. Zdravniški vestnik,6 June/July 2008),427 432 1318-0347 - 61.
Starčič Erjavec. M. Arbiter T. Žgur-Bertok D. 2009 Pathogenicity islands, plasmids and iron uptake systems in extraintestinal pathogenic strains. Acta biologica slovenica,52 2 73 83 1408-3671 - 62.
Starčič Erjavec. M. Jesenko B. Petkovšek Ž. Žgur-Bertok D. 2010 Prevalence and associations of , a gene encoding a Toll/interleukin-1 receptor domain-containing protein, among Escherichia coli urinary tract infection, skin and soft tissue infection, and commensal isolates. Journal of Clinical Microbiology,48 3 March 2010),966 968 0095-1137 - 63.
Thanassi D. G. Saulino E. T. Hultgren S. J. 1998 The chaporene/usher pathway: a major terminal branch of the general secretory pathway.1 2 April 1998),223 231 1369-5274 - 64.
Trautner B. W. Hull R. A. Darouiche R. O. 2005 Colicins prevent colonization of urinary catheters. ,56 2 August 2005),413 415 0305-7453 - 65.
Whittam T. S. Ochman H. Selander R. K. 1983 Multilocus genetic structure in natural populations of . Proceedings of the National Academy of Sciences of the United States of America,80 6 March 1983),1751 1755 0027-8424 - 66.
Xie Y. Kim K. J. Kim K. S. 2004 Current concepts on K1 translocation of the blood-brain barrier. FEMS Immunology and Medical Microbiology,42 3 November, 2004),271 279 0928-8244 - 67.
Yilmaz N. Agus N. Yurtsever S. G. Pullukcu H. Gulay Z. Coskuner A. Kose S. Aydemir S. Gulenc N. Ozgenc O. 2009 Prevalence and antimicrobial susceptibility of in outpatient urinary isolates in Izmir, Turkey. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research,15 11 November 2009),PI61 PI65 1234-1010 - 68.
Zhang L. Foxman B. 2003 Molecular epidemiology of mediated urinary tract infections. Frontiers in Bioscience,8 January 2003),e235 e244 1093-9946